Global Drug Screening Market valued at $4.8 Billion (2020), is growing at a healthy CAGR of 15.8% - Top Market Players are Quest Diagnostics, Abbott, LabCorp, Clinical Reference Laboratory, Orasure, Quidel, Thermo Fisher, DrugScan, Lion Laboratories, Drä

Drug screening is vastly used at workplaces for testing employees, in the criminal justice system, pain management clinics, Federal drug testing programs and in hospitals.

COVID-19 pandemic has led to a rapid rise in Drug Abuse

The COVID-19 pandemic has pushed more than 100 million people into unemployment. Mental health issues are also on the rise globally. This has led to a potential increase in drug abuse. Simultaneously, drug traffickers have quickly recovered from initial setbacks caused by lockdown restrictions, driven in part by an increase in the utilization of modern technology and cryptocurrency payments that are operating outside the regular financial system. These factors are likely to increase the demand for drug screening products/services.

"The pandemic has fuelled discussions about substance use disorders (SUDs), as drug and alcohol use along with the associated deaths from their overdoses increased. Confusion, loneliness, and unemployment caused many people to either start/increase drugs and alcohol consumption, when many treatment centers and support groups were unavailable during the pandemic" - CEO, Leading Drug and Alcohol Screening Laboratory, USA

United States has witnessed a 30% rise in deaths related to Drug Overdose in 2020

During the COVID-19 pandemic, United States has witnessed a worse substance abuse crisis. More than one in ten adults started/increased the consumption of alcohol or drugs during the pandemic. This resulted an increase in drug overdose-related deaths. According to CDC statistics, deaths due to drug overdose has recorded a 30% increase in 2020 and reached over 93,000 from about 72,000 deaths in 2019. This has vastly increased the demand for drug screening in USA. The global drug screening market growth is driven by increasing drug use after COVID-19 pandemic and rise in abuse of illicit drugs.

Geographic Overview: Global Drug Screening Market

Comprehensive regional analysis of the global drug screening market suggests that United States is currently the largest market for drug screening. The primary reason being - drug screening is mandatory/legal for all private or public employees in US. The employers are allowed to perform random tests for their existing employees as well as pre-employment test in case of hiring new employees. Whereas, pre-employment or random screening is banned in many European countries. The unfavorable regulations have been the major growth hurdle in the European drug screening market.

The established and emerging players operating in the drug screening market are Quest Diagnostics, Abbott, LabCorp, Clinical Reference Laboratory, Inc., Orasure Technologies, Quidel, Thermo Fisher, DrugScan, Inc., Lion Laboratories, Drägerwerk, and Intoximeters.

Explore Detailed Research Insights on Drug Screening Market @ https://meditechinsights.com/global-drug-screening-market/

Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com
https://meditechinsights.com/

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have successfully completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

This release was published on openPR.